Ula V Jurkunas1, Maya Bitar, Ian Rawe. 1. Massachusetts Eye and Ear Infirmary, Boston, Massachusetts 02114, USA. ula_jurkunas@meei.harvard.edu
Abstract
PURPOSE: To investigate the differential expression of TGFBIp in normal human and Fuchs endothelial corneal dystrophy (FECD) endothelial cell-Descemet's membrane (HCEC-DM) complex, and to asses the structural role of TGFBIp and clusterin (CLU) in guttae formation. METHODS: HCEC-DM complex was dissected from stroma in normal and FECD samples. Proteins were separated by 2-D gel electrophoresis and subjected to proteomic analysis. N-terminal processing of TGFBIp was detected by Western blot analysis with two separate antibodies against the N- and C-terminal regions of TGFBIp. Expression of TGFBI mRNA was compared by using real-time PCR. Subcellular localization of TGFBIp and CLU in corneal guttae was assessed by fluorescence confocal microscopy. RESULTS: A major 68-kDa fragment and a minor 39-kDa fragment of TGFBIp were identified on 2-D gels. Western blot analysis revealed an age-dependent proteolytic processing of the TGFBIp N terminus resulting in the increased formation of 57-kDa (P = 0.04) and 39-kDa (P = 0.03) fragments in older donors. FECD HCEC-DM showed a significant increase in the 68-kDa (P = 0.04), 57-kDa (P = 0.01), and 39- kDa (P = 0.03) fragments of TGFBIp. Real-time PCR analysis revealed that TGFBI mRNA was significantly increased (P = 0.04) in FECD samples. TGFBIp formed aggregates at the lower portions of guttae, next to Descemet's membrane, whereas CLU localized mostly on top of the TGFBIp-stained areas at the level of the endothelial cell nuclear plane. CONCLUSIONS: The overexpression of proaggregative protein CLU, and proadhesive protein TGFBIp, have been colocalized in the guttae. Such findings provide us with a better understanding of the major contributors involved in the aberrant cell-extracellular matrix interactions seen in the guttae of patients with FECD.
PURPOSE: To investigate the differential expression of TGFBIp in normal human and Fuchs endothelial corneal dystrophy (FECD) endothelial cell-Descemet's membrane (HCEC-DM) complex, and to asses the structural role of TGFBIp and clusterin (CLU) in guttae formation. METHODS:HCEC-DM complex was dissected from stroma in normal and FECD samples. Proteins were separated by 2-D gel electrophoresis and subjected to proteomic analysis. N-terminal processing of TGFBIp was detected by Western blot analysis with two separate antibodies against the N- and C-terminal regions of TGFBIp. Expression of TGFBI mRNA was compared by using real-time PCR. Subcellular localization of TGFBIp and CLU in corneal guttae was assessed by fluorescence confocal microscopy. RESULTS: A major 68-kDa fragment and a minor 39-kDa fragment of TGFBIp were identified on 2-D gels. Western blot analysis revealed an age-dependent proteolytic processing of the TGFBIp N terminus resulting in the increased formation of 57-kDa (P = 0.04) and 39-kDa (P = 0.03) fragments in older donors. FECDHCEC-DM showed a significant increase in the 68-kDa (P = 0.04), 57-kDa (P = 0.01), and 39- kDa (P = 0.03) fragments of TGFBIp. Real-time PCR analysis revealed that TGFBI mRNA was significantly increased (P = 0.04) in FECD samples. TGFBIp formed aggregates at the lower portions of guttae, next to Descemet's membrane, whereas CLU localized mostly on top of the TGFBIp-stained areas at the level of the endothelial cell nuclear plane. CONCLUSIONS: The overexpression of proaggregative protein CLU, and proadhesive protein TGFBIp, have been colocalized in the guttae. Such findings provide us with a better understanding of the major contributors involved in the aberrant cell-extracellular matrix interactions seen in the guttae of patients with FECD.
Authors: Ula V Jurkunas; Maya S Bitar; Ian Rawe; Deshea L Harris; Kathryn Colby; Nancy C Joyce Journal: Invest Ophthalmol Vis Sci Date: 2008-03-31 Impact factor: 4.799
Authors: K Hashimoto; M Noshiro; S Ohno; T Kawamoto; H Satakeda; Y Akagawa; K Nakashima; A Okimura; H Ishida; T Okamoto; H Pan; M Shen; W Yan; Y Kato Journal: Biochim Biophys Acta Date: 1997-03-01
Authors: E Korvatska; F L Munier; P Chaubert; M X Wang; Y Mashima; M Yamada; S Uffer; L Zografos; D F Schorderet Journal: Invest Ophthalmol Vis Sci Date: 1999-09 Impact factor: 4.799
Authors: Xinping C Zhao; Hisashi Nakamura; Sumitra Subramanyam; Lee E Stock; Thomas E Gillette; Shunichi Yoshikawa; Xiaoping Ma; Richard W Yee Journal: Ophthalmology Date: 2007-11 Impact factor: 12.079
Authors: M Okada; S Yamamoto; M Tsujikawa; H Watanabe; Y Inoue; N Maeda; Y Shimomura; K Nishida; A J Quantock; S Kinoshita; Y Tano Journal: Am J Ophthalmol Date: 1998-10 Impact factor: 5.258
Authors: Ula V Jurkunas; Ian Rawe; Maya S Bitar; Cheng Zhu; Deshea L Harris; Kathryn Colby; Nancy C Joyce Journal: Invest Ophthalmol Vis Sci Date: 2008-03-31 Impact factor: 4.799
Authors: Henrik Karring; Kasper Runager; Zuzana Valnickova; Ida B Thøgersen; Torben Møller-Pedersen; Gordon K Klintworth; Jan J Enghild Journal: Exp Eye Res Date: 2009-09-26 Impact factor: 3.467
Authors: Stephan Ong Tone; Matthew James Bruha; Myriam Böhm; Christina Prescott; Ula Jurkunas Journal: Can J Ophthalmol Date: 2019-06-17 Impact factor: 1.882
Authors: Young Joo Shin; Jeong Hun Kim; Jong Mo Seo; Sang Mok Lee; Joon Young Hyon; Young Suk Yu; Won Ryang Wee Journal: Mol Vis Date: 2009-12-16 Impact factor: 2.367